Table 1.
Characteristic | Study population (N=158) | Percentage |
---|---|---|
Demographics | ||
Age (years ± SD) | 49.66 ± 11.54 | |
Sex | ||
Men | 30 | 19.0 |
Women | 128 | 81.0 |
Race | ||
Caucasian | 127 | 80.4 |
Hispanic/Latino | 6 | 3.8 |
Black/African American | 4 | 2.5 |
Other | 6 | 3.8 |
Unknown | 19 | 12.0 |
Disease-modifying therapy | ||
None | 13 | 8.2 |
Injectable | 24 | 15.2 |
Oral | 53 | 33.5 |
Intravenous | 68 | 43.0 |
Disease duration (years ± SD) | 12.33 ± 8.26 |